INO
Inovio Pharmaceuticals Inc
Price:  
2.08 
USD
Volume:  
911,964.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

INO WACC - Weighted Average Cost of Capital

The WACC of Inovio Pharmaceuticals Inc (INO) is 8.0%.

The Cost of Equity of Inovio Pharmaceuticals Inc (INO) is 8.70%.
The Cost of Debt of Inovio Pharmaceuticals Inc (INO) is 6.65%.

Range Selected
Cost of equity 7.10% - 10.30% 8.70%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 6.30% - 7.00% 6.65%
WACC 6.7% - 9.4% 8.0%
WACC

INO WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.71 0.98
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.10% 10.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.22 0.22
Cost of debt 6.30% 7.00%
After-tax WACC 6.7% 9.4%
Selected WACC 8.0%